BIOLIFE LABS LIMITED

Executive Summary

BIOLIFE LABS LIMITED operates in the "Other human health activities" sector but remains dormant with no trading history or financial activity. As a non-operational entity, it currently holds no competitive position or measurable performance against active industry peers, who are typically engaged in technologically intensive, regulated health services. The company’s future impact will depend on its transition from dormancy into active participation amid evolving healthcare market trends.

View Full Analysis Report →
Legal registered address
156 Cromwell Road 1st Floor London Uk England SW7 4EF Copied!

Company number
12568608 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Dormant
Incorporated on
22 April 2020
Accounts

Latest annual accounts were to 31 July 2024

Next annual accounts are due by 30 April 2026

Company financial year end is on 31 July 2026

Confirmation statement

Latest confirmation statement statement dated 18 August 2024

Next statement due by 1 September 2025

View original and historic source data
Nature of business (SIC)

86900 - Other human health activities

Latest company documents
DateDescription
29/04/2529 April 2025 Accounts for a dormant company made up to 2024-07-31

View Document

29/10/2429 October 2024 Termination of appointment of Ameer Singh Bahl as a director on 2024-10-29

View Document

29/10/2429 October 2024 Notification of Ashwin Prafulchandra Patel as a person with significant control on 2024-10-29

View Document

29/10/2429 October 2024 Cessation of Ameer Singh Bahl as a person with significant control on 2024-10-29

View Document

29/10/2429 October 2024 Termination of appointment of Dawn Pharma Group Ltd as a director on 2024-10-29

View Document

View all company documents

More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company